CANONICAL MEDICINE ENGINE V340.6 ⢠100 EXPANDED MONOGRAPHS
Canonical Medicine Monograph Reference Engine (V340.6 Expansion)
Retrieving verified pharmacology, CDSCO Schedule classification, NLEM 2022 essential status, verified Indian brand registry, pharmacokinetics (ADME), renal/hepatic dosing adjustments, and clinical counselling guidance from THE INDIAN PHARMACIST 744-profile canonical database (Indian Pharmacopoeia & NFI, NCBI StatPearls, US FDA DailyMed).
Complete Index of 100 Expanded V340.6 Canonical Medicine Monographs ([V340.6-001] to [V340.6-100])
- [V340.6-001] Vericiguat (Vericiguat) ā Cardiovascular & Haematology (Ch 03) • Soluble Guanylate Cyclase (sGC) Stimulator • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Verquvo (Bayer Zydus Pharma)
- [V340.6-002] Bempedoic Acid (Bempedoic Acid) ā Cardiovascular & Haematology (Ch 03) • ATP Citrate Lyase (ACL) Inhibitor (Non-Statin Lipid-Lowering Agent) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Bemdac (Zydus Lifesciences), Brillo (Torrent Pharmaceuticals)
- [V340.6-003] Inclisiran Sodium (Inclisiran) ā Cardiovascular & Haematology (Ch 03) • PCSK9-Targeting Small Interfering RNA (siRNA) Lipid-Lowering Agent • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Sybrava (Novartis India), Leqvio (Novartis)
- [V340.6-004] Evolocumab (Evolocumab) ā Cardiovascular & Haematology (Ch 03) • PCSK9 Inhibitor Monoclonal Antibody • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Repatha (Amgen / Dr. Reddy's Laboratories ā 140 mg/mL SureClick)
- [V340.6-005] Fondaparinux Sodium (Fondaparinux Sodium) ā Cardiovascular & Haematology (Ch 03) • Selective Indirect Factor Xa Inhibitor (Synthetic Pentasaccharide Anticoagulant) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Arixtra (Dr. Reddy's / GSK), Fondakem (Alkem)
- [V340.6-006] Bivalirudin Trifluoroacetate (Bivalirudin) ā Cardiovascular & Haematology (Ch 03) • Direct Reversible Thrombin (Factor IIa) Inhibitor (Parenteral Anticoagulant) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Bivalirud (Cipla), Bivastat (Gland Pharma)
- [V340.6-007] Alteplase (Recombinant Tissue Plasminogen Activator ā r-tPA) (Alteplase) ā Cardiovascular & Haematology (Ch 03) • Fibrin-Specific Recombinant Thrombolytic / Fibrinolytic Agent • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Actilyse (Boehringer Ingelheim India ā 20 mg, 50 mg)
- [V340.6-008] Tenecteplase (TNK-tPA) (Tenecteplase) ā Cardiovascular & Haematology (Ch 03) • Third-Generation Fibrin-Specific Single-Bolus Thrombolytic Agent • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Elaxim (Gennova Biopharmaceuticals ā 20 mg, 30 mg, 40 mg, 50 mg), Metalyse (Boehringer Ingelheim)
- [V340.6-009] Adenosine (Adenosine) ā Cardiovascular & Haematology (Ch 03) • Endogenous Purine Nucleoside A1-Receptor Agonist (Class V Antiarrhythmic) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Adenocor (Sanofi India ā 6 mg/2 mL), Adenoz (Sun Pharma)
- [V340.6-010] Flecainide Acetate (Flecainide Acetate) ā Cardiovascular & Haematology (Ch 03) • Vaughan Williams Class IC Sodium Channel Blocker Antiarrhythmic (Narrow Therapeutic Index) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Flecarite (Torrent Pharmaceuticals ā 50 mg, 100 mg)
- [V340.6-011] Bosentan Monohydrate (Bosentan) ā Cardiovascular & Haematology (Ch 03) • Dual Endothelin Receptor Antagonist (ERA ā ETA and ETB Antagonist) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Bosentas (Cipla ā 62.5 mg, 125 mg), Bozetan (MSN)
- [V340.6-012] Ambrisentan (Ambrisentan) ā Cardiovascular & Haematology (Ch 03) • Selective Endothelin Type-A (ETA) Receptor Antagonist (PAH Vasodilator) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Pulmonext (MSN ā 5 mg, 10 mg), Endobloc (Cipla ā 5 mg, 10 mg)
- [V340.6-013] Tirzepatide (Tirzepatide) ā Endocrinology & Diabetes (Ch 04) • Dual GIP and GLP-1 Receptor Agonist ('Twincretin') • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Mounjaro (Eli Lilly and Company India)
- [V340.6-014] Imeglimin Hydrochloride (Imeglimin Hydrochloride) ā Endocrinology & Diabetes (Ch 04) • Tetrahydrotriazine Mitochondrial Bioenergetics Modulator ('Glimin' Antidiabetic) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Imeglyn (Zydus Lifesciences ā 500 mg, 1000 mg), Imeglim (Torrent Pharmaceuticals)
- [V340.6-015] Remogliflozin Etabonate (Remogliflozin Etabonate) ā Endocrinology & Diabetes (Ch 04) • Selective Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitor • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Remo / Remo-M / Remo-V (Glenmark ā 100 mg), Zucator (Torrent Pharmaceuticals)
- [V340.6-016] Insulin Glulisine (rDNA Origin) (Insulin Glulisine) ā Endocrinology & Diabetes (Ch 04) • Rapid-Acting Prandial Human Insulin Analogue • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Apidra (Sanofi India ā 100 IU/mL SoloStar Pen, Cartridge & Vial)
- [V340.6-017] Octreotide Acetate (Octreotide Acetate) ā Endocrinology & Diabetes (Ch 04) • Synthetic Somatostatin Analogue (SSTR2 / SSTR5 Agonist) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Sandostatin / Sandostatin LAR (Novartis), Octride (Sun Pharma)
- [V340.6-018] Leuprolide Acetate (Leuprorelin Acetate) (Leuprolide Acetate) ā Endocrinology & Diabetes (Ch 04) • Gonadotropin-Releasing Hormone (GnRH / LHRH) Receptor Agonist • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Lupride Depot (Sun Pharma ā 3.75 mg, 11.25 mg, 22.5 mg), Eligard (Dr. Reddy's)
- [V340.6-019] Goserelin Acetate (Goserelin Acetate) ā Endocrinology & Diabetes (Ch 04) • Biodegradable Subcutaneous Implant GnRH Superagonist • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Zoladex / Zoladex LA (AstraZeneca Pharma India ā 3.6 mg, 10.8 mg SafeSystem Syringe)
- [V340.6-020] Cinacalcet Hydrochloride (Cinacalcet Hydrochloride) ā Endocrinology & Diabetes (Ch 04) • Allosteric Calcium-Sensing Receptor (CaSR) Agonist (Calcimimetic) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Mimicip (Cipla ā 30 mg, 60 mg), PTH-30 / PTH-60 (Intas)
- [V340.6-021] Liothyronine Sodium (L-Triiodothyronine ā T3) (Liothyronine Sodium) ā Endocrinology & Diabetes (Ch 04) • Synthetic Active Thyroid Hormone (Triiodothyronine ā T3) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Linorma (Macleods Pharmaceuticals ā 5 mcg, 20 mcg), Cytomel (reference)
- [V340.6-022] Raloxifene Hydrochloride (Raloxifene Hydrochloride) ā Endocrinology & Diabetes (Ch 04) • Second-Generation Selective Oestrogen Receptor Modulator (SERM) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Ralista (Cipla ā 60 mg), Bonmax (Zydus ā 60 mg)
- [V340.6-023] Umeclidinium Bromide (Umeclidinium Bromide) ā Respiratory & Allergy (Ch 09) • Long-Acting Muscarinic Antagonist (LAMA) Inhaled Bronchodilator • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Incruse Ellipta (GlaxoSmithKline), Anoro Ellipta [with Vilanterol] (GSK)
- [V340.6-024] Fluticasone Furoate + Vilanterol Trifenatate (Fluticasone Furoate + Vilanterol) ā Respiratory & Allergy (Ch 09) • Once-Daily Inhaled Corticosteroid (ICS) + Ultra-LABA Fixed-Dose Combination • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Relvar Ellipta (GSK ā 100/25 mcg, 200/25 mcg), Flutiflo-V (Lupin)
- [V340.6-025] Ciclesonide (Ciclesonide) ā Respiratory & Allergy (Ch 09) • Soft-Drug Ester Prodrug Inhaled & Intranasal Corticosteroid • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Ciclez (Cipla ā 80 mcg, 160 mcg MDI/Rotacaps & 50 mcg Nasal Spray), Alvesco / Omnaris (reference)
- [V340.6-026] Omalizumab (Omalizumab) ā Respiratory & Allergy (Ch 09) • Recombinant Humanised Anti-Immunoglobulin E (Anti-IgE) Monoclonal Antibody • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Xolair (Novartis India ā 150 mg), Omalirel (Reliance Life Sciences ā 150 mg)
- [V340.6-027] Mepolizumab (Mepolizumab) ā Respiratory & Allergy (Ch 09) • Humanised Interleukin-5 (IL-5) Antagonist Monoclonal Antibody • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Nucala (GlaxoSmithKline Pharmaceuticals ā 100 mg/mL)
- [V340.6-028] Pirfenidone (Pirfenidone) ā Respiratory & Allergy (Ch 09) • Pyridone Antifibrotic & TGF-Beta / TNF-Alpha Synthesis Inhibitor • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Pirfenex (Cipla ā 200 mg, 400 mg), Fibrodone (Lupin)
- [V340.6-029] Nintedanib Esylate (Nintedanib) ā Respiratory & Allergy (Ch 09) • Triple Angiokinase Inhibitor (VEGFR 1ā3, FGFR 1ā3, PDGFR α/β TKI) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Ofev (Boehringer Ingelheim ā 100 mg, 150 mg), Nintena (Cipla ā 100 mg, 150 mg)
- [V340.6-030] Rupatadine Fumarate (Rupatadine) ā Respiratory & Allergy (Ch 09) • Dual Second-Generation H1-Antihistamine & Platelet-Activating Factor (PAF) Antagonist • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Rupanex (Dr. Reddy's ā 10 mg), Smarti (Macleods ā 10 mg)
- [V340.6-031] Vonoprazan Fumarate (Vonoprazan) ā Gastroenterology & Hepatology (Ch 05) • Potassium-Competitive Acid Blocker (P-CAB ā Reversible H+/K+-ATPase Inhibitor) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Vono (Macleods ā 10 mg, 20 mg), Vonopraz (Sun Pharma ā 10 mg, 20 mg)
- [V340.6-032] Prucalopride Succinate (Prucalopride) ā Gastroenterology & Hepatology (Ch 05) • Selective High-Affinity Serotonin 5-HT4 Receptor Agonist Enterokinetic • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Pruvict (Torrent ā 1 mg, 2 mg), Prudac (Zydus ā 1 mg, 2 mg)
- [V340.6-033] Linaclotide (Linaclotide) ā Gastroenterology & Hepatology (Ch 05) • Guanylate Cyclase-C (GC-C) Receptor Agonist Secretagogue Peptide • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Constella (AbbVie), Linaclo (Specialty GI reference)
- [V340.6-034] Lubiprostone (Lubiprostone) ā Gastroenterology & Hepatology (Ch 05) • Selective Type-2 Chloride Channel (ClC-2) Activator (Prostone Intestinal Secretagogue) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Lubowel (Sun Pharma ā 8 mcg, 24 mcg), Amitiza (Takeda)
- [V340.6-035] Aprepitant & Fosaprepitant Dimeglumine (Aprepitant) ā Gastroenterology & Hepatology (Ch 05) • Selective Substance P / Neurokinin-1 (NK1) Receptor Antagonist Antiemetic • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Aprecap (Glenmark ā 125/80/80 mg Combi-Kit), Apriset (Sun Pharma)
- [V340.6-036] Palonosetron Hydrochloride (Palonosetron Hydrochloride) ā Gastroenterology & Hepatology (Ch 05) • Second-Generation High-Affinity 5-HT3 Receptor Antagonist Antiemetic • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Palzen (Dr. Reddy's ā 0.25 mg/5 mL IV), Chemotron (Lupin ā 0.25 mg IV)
- [V340.6-037] Terlipressin Acetate (Terlipressin Acetate) ā Gastroenterology & Hepatology (Ch 05) • Synthetic Triglycyl-Lysine Vasopressin Prodrug (Selective V1a Splanchnic Vasoconstrictor) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Terlinis (Neiss ā 1 mg/10 mL), Glypressin (Ferring)
- [V340.6-038] Obeticholic Acid (Obeticholic Acid) ā Gastroenterology & Hepatology (Ch 05) • Semi-Synthetic Farnesoid X Receptor (FXR) Agonist (Bile Acid Analogue) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Obetix (Dr. Reddy's ā 5 mg, 10 mg), Udchol-OCA (Sun Pharma)
- [V340.6-039] Brivaracetam (Brivaracetam) ā Neurology & Psychiatry (Ch 11) • High-Affinity Synaptic Vesicle Glycoprotein 2A (SV2A) Ligand Antiepileptic • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Briviact (UCB India ā 25 mg, 50 mg, 75 mg, 100 mg, Oral Solution & IV), Brivasure (Sun Pharma)
- [V340.6-040] Perampanel (Perampanel) ā Neurology & Psychiatry (Ch 11) • Selective Non-Competitive AMPA Glutamate Receptor Antagonist Antiepileptic • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Fycompa (Eisai India ā 2 mg, 4 mg, 6 mg, 8 mg), Peramp (Intas)
- [V340.6-041] Zonisamide (Zonisamide) ā Neurology & Psychiatry (Ch 11) • Benzisoxazole Sulfonamide Broad-Spectrum Antiepileptic (Nav / T-Type Cav Blocker) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Zonegran (Eisai India ā 25 mg, 50 mg, 100 mg), Zonit (Torrent ā 50 mg, 100 mg)
- [V340.6-042] Ethosuximide (Ethosuximide) ā Neurology & Psychiatry (Ch 11) • Succinimide Thalamic T-Type Calcium Channel Blocker (Absence Seizure Antiepileptic) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Absenz (Sun Pharma ā 250 mg/5 mL Syrup), Zarontin (Pfizer ā 250 mg Capsule / Syrup)
- [V340.6-043] Vortioxetine Hydrobromide (Vortioxetine) ā Neurology & Psychiatry (Ch 11) • Multimodal Serotonin Transporter (SERT) Inhibitor & 5-HT Receptor Modulator Antidepressant • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Brintellix (Lundbeck India ā 5 mg, 10 mg, 15 mg, 20 mg), Vortidif (Sun Pharma)
- [V340.6-044] Agomelatine (Agomelatine) ā Neurology & Psychiatry (Ch 11) • Melatonergic MT1/MT2 Receptor Agonist & 5-HT2C Receptor Antagonist Antidepressant • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Agoprex (Servier India ā 25 mg), Sami (Sun Pharma ā 25 mg)
- [V340.6-045] Atomoxetine Hydrochloride (Atomoxetine Hydrochloride) ā Neurology & Psychiatry (Ch 11) • Selective Norepinephrine Reuptake Inhibitor (sNRI ā Non-Stimulant ADHD Agent) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Axepta (Intas ā 10 mg, 18 mg, 25 mg, 40 mg, 60 mg), Attentrol (Sun Pharma ā 10 mg, 18 mg, 25 mg, 40 mg)
- [V340.6-046] Modafinil & Armodafinil (Modafinil) ā Neurology & Psychiatry (Ch 11) • Non-Amphetamine Central Wakefulness-Promoting Agent (Eugeroic) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Modalert (Sun Pharma ā 100 mg, 200 mg Modafinil), Waklert (Sun Pharma ā 50 mg, 150 mg Armodafinil)
- [V340.6-047] Rasagiline Mesylate & Selegiline Hydrochloride (Rasagiline Mesylate) ā Neurology & Psychiatry (Ch 11) • Selective Irreversible Monoamine Oxidase-B (MAO-B) Inhibitor (Antiparkinsonian) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Rasagin (Natco ā 0.5 mg, 1 mg), Relgin (Intas ā 0.5 mg, 1 mg)
- [V340.6-048] Pyridostigmine Bromide & Neostigmine Methylsulphate (Pyridostigmine Bromide) ā Neurology & Psychiatry (Ch 11) • Reversible Quaternary Ammonium Acetylcholinesterase Inhibitor (Cholinergic Agent) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Gravitor (Sun Pharma ā 60 mg, 180 mg SR), Myestin (VHB ā 60 mg)
- [V340.6-049] Daptomycin (Daptomycin) ā Infectious Diseases & Antimicrobials (Ch 08) • Cyclic Lipopeptide Bactericidal Reserve Antibiotic (Gram-Positive) • Schedule H1 (Drugs Rules, 1945 ā 3-Year Register & Reserve Antibiotic Control) • Brands: Cubicin (MSD ā 350 mg, 500 mg), Daptocure (Emcure ā 350 mg, 500 mg)
- [V340.6-050] Minocycline Hydrochloride (Minocycline Hydrochloride) ā Infectious Diseases & Antimicrobials (Ch 08) • Lipophilic Second-Generation Semi-Synthetic Tetracycline Antibiotic • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Minoz (Sun Pharma ā 50 mg, 100 mg & ER 45/65 mg), Cynomycin (Pfizer ā 50 mg, 100 mg)
- [V340.6-051] Aztreonam (Aztreonam) ā Infectious Diseases & Antimicrobials (Ch 08) • Monobactam Parenteral Beta-Lactam Antibiotic (Aerobic Gram-Negative & NDM Metallo-Beta-Lactamase Stable) • Schedule H1 (Drugs Rules, 1945 ā 3-Year Register & Reserve Antibiotic Control) • Brands: Trezam (Cipla ā 500 mg, 1 g, 2 g), Azenam (Aristo ā 500 mg, 1 g, 2 g)
- [V340.6-052] Caspofungin Acetate (Caspofungin) ā Infectious Diseases & Antimicrobials (Ch 08) • Echinocandin 1,3-Beta-D-Glucan Synthase Inhibitor (Parenteral Systemic Antifungal) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Cancidas (MSD ā 50 mg, 70 mg), Casfung (Glenmark ā 50 mg, 70 mg)
- [V340.6-053] Micafungin Sodium & Anidulafungin (Micafungin Sodium) ā Infectious Diseases & Antimicrobials (Ch 08) • Echinocandin 1,3-Beta-D-Glucan Synthase Inhibitor • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Mycamine (Astellas ā 50 mg, 100 mg), Micacan (Cipla ā 50 mg, 100 mg)
- [V340.6-054] Amphotericin B (Liposomal & Deoxycholate) (Amphotericin B) ā Infectious Diseases & Antimicrobials (Ch 08) • Polyene Macrolide Broad-Spectrum Systemic Antifungal & Antileishmanial • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Ambisome (Gilead / Mylan ā 50 mg Liposomal), Fungisome (Lifecare ā 10 mg, 25 mg, 50 mg Liposomal)
- [V340.6-055] Posaconazole & Isavuconazole (Posaconazole) ā Infectious Diseases & Antimicrobials (Ch 08) • Extended-Spectrum Second-Generation Triazole Systemic Antifungal (Active Against Aspergillus & Mucorales) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Noxafil (MSD ā 100 mg GR Tablet, 40 mg/mL Suspension & 300 mg IV), Posanat (Natco ā 100 mg GR Tablet)
- [V340.6-056] Valganciclovir Hydrochloride & Ganciclovir (Valganciclovir Hydrochloride) ā Infectious Diseases & Antimicrobials (Ch 08) • L-Valyl Ester Prodrug of Ganciclovir (Guanosine Nucleoside Analogue Anti-CMV Agent) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Valcept (Cipla ā 450 mg Tablet), Natclovir (Natco ā Ganciclovir 250 mg Cap / 500 mg IV)
- [V340.6-057] Clofazimine (Clofazimine) ā Infectious Diseases & Antimicrobials (Ch 08) • Riminophenazine Antimycobacterial & Anti-Inflammatory Agent • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Hansepran (Abbott Healthcare ā 50 mg, 100 mg), Clofozine (Macleods)
- [V340.6-058] Dapsone (4,4'-Diaminodiphenyl Sulfone ā DDS) (Dapsone) ā Infectious Diseases & Antimicrobials (Ch 08) • Sulfone Dihydropteroate Synthase Inhibitor (Antileprotic, Anti-PJP & Anti-Inflammatory) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Dapsone (GSK ā 100 mg Tablet), Acnedap (Cipla ā 5% Topical Gel)
- [V340.6-059] Praziquantel (Praziquantel) ā Infectious Diseases & Antimicrobials (Ch 08) • Pyrazinoisoquinoline Anthelmintic (Cestodicide & Trematodicide) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Distocide (Chandra Bhagat / Shin Poong ā 600 mg), Cysticide (Merck ā 500 mg, 600 mg)
- [V340.6-060] Nitazoxanide (Nitazoxanide) ā Infectious Diseases & Antimicrobials (Ch 08) • Thiazolide Pyruvate:Ferredoxin Oxidoreductase (PFOR) Inhibitor (Antiprotozoal & Anthelmintic) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Nizonide (Lupin ā 200 mg, 500 mg Tablet & 100 mg/5 mL Suspension), Nitacure (Alembic ā 500 mg)
- [V340.6-061] Ribociclib Succinate (Ribociclib) ā Oncology & Immunology (Ch 12) • Selective Cyclin-Dependent Kinase 4 and 6 (CDK4/6) Inhibitor (Targeted Breast Cancer Agent) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Kryxana (Novartis India ā 200 mg), Kisqali (Novartis ā 200 mg)
- [V340.6-062] Everolimus & Sirolimus (Rapamycin) (Everolimus) ā Oncology & Immunology (Ch 12) • Mechanistic Target of Rapamycin Complex 1 (mTORC1) Allosteric Inhibitor • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Afinitor (Novartis ā 5 mg, 10 mg Oncology), Certican (Novartis ā 0.25 mg, 0.5 mg, 0.75 mg Transplant)
- [V340.6-063] Nivolumab (Nivolumab) ā Oncology & Immunology (Ch 12) • Programmed Death-1 (PD-1) Immune Checkpoint Inhibitor Monoclonal Antibody • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Opdyta / Opdivo (Bristol-Myers Squibb India ā 40 mg/4 mL, 100 mg/10 mL)
- [V340.6-064] Bevacizumab (Bevacizumab) ā Oncology & Immunology (Ch 12) • Recombinant Humanised Anti-VEGF-A Monoclonal Antibody (Angiogenesis Inhibitor) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Avastin (Roche ā 100 mg/4 mL, 400 mg/16 mL), Krabeva (Biocon)
- [V340.6-065] Sorafenib Tosylate & Sunitinib Malate (Sorafenib Tosylate) ā Oncology & Immunology (Ch 12) • Multi-Kinase VEGFR / PDGFR / RAF Tyrosine Kinase Inhibitor • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Sorafenat (Natco ā 200 mg), Soranib (Cipla ā 200 mg)
- [V340.6-066] Dasatinib & Nilotinib (Dasatinib) ā Oncology & Immunology (Ch 12) • Second-Generation BCR-ABL1 & Src-Family Tyrosine Kinase Inhibitor (CML & Ph+ ALL) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Sprycel (BMS ā 20 mg, 50 mg, 70 mg, 100 mg), Dasanat (Natco ā 50 mg, 70 mg, 100 mg)
- [V340.6-067] Olaparib (Olaparib) ā Oncology & Immunology (Ch 12) • Poly(ADP-Ribose) Polymerase (PARP1 / PARP2 / PARP3) Inhibitor (Synthetic Lethality Targeted Oncolytic) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Lynparza (AstraZeneca / MSD India ā 100 mg, 150 mg Tablets), Olapar (Zydus ā 100 mg, 150 mg)
- [V340.6-068] Venetoclax (Venetoclax) ā Oncology & Immunology (Ch 12) • Selective BCL-2 Antagonist (BH3-Mimetic Apoptosis Inducer) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Venclyxto (AbbVie ā 10 mg, 50 mg, 100 mg)
- [V340.6-069] Daratumumab (Daratumumab) ā Oncology & Immunology (Ch 12) • Human IgG1k Anti-CD38 Monoclonal Antibody (Multiple Myeloma Immunotherapy) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Darzalex (Janssen / Johnson & Johnson India ā 100 mg/5 mL, 400 mg/20 mL IV & 1,800 mg SC)
- [V340.6-070] Hydroxyurea (Hydroxycarbamide) (Hydroxyurea) ā Oncology & Immunology (Ch 12) • Ribonucleotide Reductase Inhibitor (Antimetabolite & Foetal Haemoglobin [HbF] Inducer) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Cytodrox (Cipla ā 500 mg), Hydrea (BMS / Sarabhai ā 500 mg)
- [V340.6-071] Finerenone (Finerenone) ā Nephrology & Urology (Ch 10 / Ch 12) • Non-Steroidal Selective Mineralocorticoid Receptor Antagonist (nsMRA) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Kerendia (Bayer Zydus Pharma ā 10 mg, 20 mg)
- [V340.6-072] Tolvaptan (Tolvaptan) ā Nephrology & Urology (Ch 10 / Ch 12) • Selective Vasopressin V2-Receptor Antagonist (Oral Aquaretic) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Natrise (Sun Pharma ā 15 mg, 30 mg), Tolvat (Torrent ā 15 mg, 30 mg)
- [V340.6-073] Desidustat & Roxadustat (Desidustat) ā Nephrology & Urology (Ch 10 / Ch 12) • Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor (HIF-PHI ā Renal Anaemia Agent) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Oxemia (Zydus Lifesciences ā 25 mg, 50 mg, 100 mg Desidustat)
- [V340.6-074] Lanthanum Carbonate & Ferric Citrate (Lanthanum Carbonate) ā Nephrology & Urology (Ch 10 / Ch 12) • Non-Calcium, Non-Aluminium Trivalent Cation Oral Phosphate Binder • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Lanthonate (Panacea Biotec ā 500 mg Chewable), Fosrenol (Takeda ā 500 mg, 750 mg, 1000 mg)
- [V340.6-075] Darifenacin Hydrobromide & Trospium Chloride (Darifenacin) ā Nephrology & Urology (Ch 12) • Selective Muscarinic M3 Receptor Antagonist & Quaternary Ammonium Antimuscarinic (OAB) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Darilong (Sun Pharma ā 7.5 mg, 15 mg ER Darifenacin), Trospium (Dr. Reddy's / Sun ā 20 mg, 60 mg XR Trospium)
- [V340.6-076] Avanafil & Udenafil (Avanafil) ā Nephrology & Urology (Ch 12) • Rapid-Onset Highly Selective Second-Generation Phosphodiesterase-5 (PDE-5) Inhibitor • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Avana (Macleods ā 50 mg, 100 mg, 200 mg Avanafil), Zudena (Dr. Reddy's ā 100 mg Udenafil)
- [V340.6-077] Probenecid & Benzbromarone (Probenecid) ā Nephrology & Urology (Ch 07 / Ch 12) • Renal Tubular URAT1 & Organic Anion Transporter (OAT1/OAT3) Inhibitor (Uricosuric & Beta-Lactam Adjunct) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Bencid (Geno Pharmaceuticals ā 500 mg)
- [V340.6-078] Adalimumab (Adalimumab) ā Dermatology & Rheumatology (Ch 07 / Ch 12) • Fully Human Anti-Tumour Necrosis Factor-Alpha (Anti-TNF-α) Monoclonal Antibody (Biologic DMARD) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Exemptia (Zydus ā 40 mg/0.8 mL), Adfrar (Torrent ā 40 mg)
- [V340.6-079] Secukinumab (Secukinumab) ā Dermatology & Rheumatology (Ch 07 / Ch 12) • Fully Human Anti-Interleukin-17A (Anti-IL-17A) Monoclonal Antibody • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Scapho (Novartis India ā 150 mg Pen/Syringe/Vial), Cosentyx (Novartis ā 150 mg, 300 mg)
- [V340.6-080] Apremilast (Apremilast) ā Dermatology & Rheumatology (Ch 07 / Ch 12) • Oral Selective Phosphodiesterase-4 (PDE4) Inhibitor (Small-Molecule Immunomodulator) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Aprezo (Glenmark ā 10 mg, 20 mg, 30 mg & Starter Pack), Apraize (Torrent)
- [V340.6-081] Upadacitinib & Abrocitinib (Upadacitinib) ā Dermatology & Rheumatology (Ch 07 / Ch 12) • Selective Janus Kinase 1 (JAK1) Inhibitor (Oral Targeted Synthetic DMARD) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Rinvoq (AbbVie ā 15 mg, 30 mg, 45 mg ER Upadacitinib), Cibinqo (Pfizer ā 50 mg, 100 mg, 200 mg Abrocitinib)
- [V340.6-082] Dupilumab (Dupilumab) ā Dermatology & Rheumatology (Ch 09 / Ch 12) • Dual Interleukin-4 and Interleukin-13 Signalling Antagonist (Anti-IL-4Rα Monoclonal Antibody) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Dupixent (Sanofi India ā 200 mg/1.14 mL, 300 mg/2 mL Pre-Filled Syringe / Pen)
- [V340.6-083] Minoxidil (Topical 2%ā10% & Low-Dose Oral) (Minoxidil) ā Dermatology & Rheumatology (Ch 12 / Ch 03) • ATP-Sensitive Potassium Channel (KATP) Opener & Follicular Anagen Inducer • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Mintop / Mintop Forte (Dr. Reddy's ā 2%, 5%, 10% Solution/Foam), Tugain (Cipla ā 2%, 5%, 10%)
- [V340.6-084] Amorolfine Hydrochloride & Ciclopirox Olamine (Amorolfine) ā Dermatology & Rheumatology (Ch 12) • Morpholine Ergosterol Delta-14-Reductase & Delta-8,7-Isomerase Inhibitor (Topical Nail Lacquer Antifungal) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Loceryl (Galderma India ā 5% w/v Nail Lacquer & 0.25% Cream), Amrolstar (Mankind ā 5% Nail Lacquer)
- [V340.6-085] Pimecrolimus & Crisaborole (Pimecrolimus) ā Dermatology & Rheumatology (Ch 12) • Non-Steroidal Topical Calcineurin Inhibitor (Cutaneous Immunomodulator) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Elidel (Viatris ā 1% Cream), Pacroma (Ajanta Pharma ā 1% Cream)
- [V340.6-086] Dobutamine Hydrochloride (Dobutamine Hydrochloride) ā Emergency, Critical Care & Anaesthesia (Ch 03 / App B) • Synthetic Catecholamine Beta-1 Selective Adrenergic Inotrope (Inodilator) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Dobustat (Samarth ā 250 mg/20 mL), Cardiject (Neon ā 250 mg/5 mL)
- [V340.6-087] Vasopressin (Argipressin) Injection (Vasopressin) ā Emergency, Critical Care & Anaesthesia (Ch 03 / App B) • Non-Adrenergic V1a Vascular & V2 Renal Receptor Agonist (Catecholamine-Sparing Vasopressor) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Cpressin (Samarth ā 20 Units/mL, 40 Units/2 mL), Vasopin (VHB ā 20 Units/mL)
- [V340.6-088] Levosimendan & Milrinone Lactate (Levosimendan) ā Emergency, Critical Care & Anaesthesia (Ch 03 / App B) • Cardiac Troponin C Calcium Sensitiser & Vascular KATP Channel Opener (Inodilator) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Simdax (Orion ā 12.5 mg/5 mL), Levosim (Cipla ā 12.5 mg/5 mL)
- [V340.6-089] Rocuronium Bromide, Vecuronium Bromide & Atracurium Besylate (Rocuronium Bromide) ā Emergency, Critical Care & Anaesthesia (Ch 11 / App B) • Intermediate-Acting Non-Depolarising Competitive Neuromuscular Blocking Agent • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Esmeron (MSD ā 50 mg/5 mL), Rocuron (Neon ā 50 mg/5 mL, 100 mg/10 mL)
- [V340.6-090] Succinylcholine Chloride (Suxamethonium Chloride) (Succinylcholine Chloride) ā Emergency, Critical Care & Anaesthesia (Ch 11 / App B) • Ultra-Short-Acting Depolarising Neuromuscular Blocking Agent • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Scoline (GSK ā 100 mg/2 mL), Succin (Neon ā 100 mg/2 mL, 500 mg/10 mL)
- [V340.6-091] Sevoflurane & Isoflurane (Sevoflurane) ā Emergency, Critical Care & Anaesthesia (Ch 11 / App B) • Halogenated Fluorinated Ether Volatile Inhalational General Anaesthetic • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Sevorane (AbbVie ā 250 mL), Sevoflo / Sevotroy (Troikaa ā 250 mL)
- [V340.6-092] Bupivacaine Hydrochloride & Lignocaine (Lidocaine) Hydrochloride (Bupivacaine Hydrochloride) ā Emergency, Critical Care & Anaesthesia (Ch 11 / App B) • Long-Acting Amide Local Anaesthetic (Spinal, Epidural & Regional Nerve Blockade) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Anawin / Anawin Heavy (Neon ā 0.25%, 0.5% Isobaric & Hyperbaric Spinal Bupivacaine), Sensorcaine (Zydus)
- [V340.6-093] Protamine Sulphate & Idarucizumab (Protamine Sulphate) ā Emergency, Critical Care & Anaesthesia (Ch 03 / App B) • Specific Heparin-Neutralising Electrostatic Antagonist & Direct Anticoagulant Reversal Agent • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Protamine Sulphate (Samarth ā 50 mg/5 mL Ampoule), Prota (Troikaa ā 50 mg/5 mL)
- [V340.6-094] Nepafenac & Bromfenac Ophthalmic (Nepafenac) ā Ophthalmology, ENT & Other (Ch 12) • Ophthalmic Non-Steroidal Anti-Inflammatory Prodrug (Amfenac Precursor) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Nevanac (Alcon / Novartis ā 0.1%, 0.3% Suspension), Nepact (Sun Pharma ā 0.1%, 0.3%)
- [V340.6-095] Ranibizumab & Aflibercept (Intravitreal Anti-VEGF) (Ranibizumab) ā Ophthalmology, ENT & Other (Ch 12) • Intravitreal Anti-VEGF-A Monoclonal Antibody Fab Fragment & Decoy Receptor Fusion Protein • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Lucentis / Accentrix (Novartis India ā 10 mg/mL), Razumab (Intas ā 10 mg/mL)
- [V340.6-096] Bimatoprost Ophthalmic (0.01% / 0.03%) (Bimatoprost) ā Ophthalmology, ENT & Other (Ch 12) • Synthetic Prostamide F2-Alpha Analogue (Uveoscleral & Trabecular Outflow Ocular Hypotensive) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Lumigan (Allergan / AbbVie ā 0.01%, 0.03%), Bimat (Ajanta ā 0.01%, 0.03%)
- [V340.6-097] Azelastine Hydrochloride (Intranasal & Ophthalmic) (Azelastine Hydrochloride) ā Ophthalmology, ENT & Other (Ch 09 / Ch 12) • Topical Intranasal & Ophthalmic Second-Generation H1-Antihistamine & Mast-Cell Stabiliser • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Arzep (Zydus ā 0.1% Nasal Spray), Duonase / Dymista [with Fluticasone Propionate] (Cipla ā 140/50 mcg Nasal Spray)
- [V340.6-098] Deferasirox & Deferoxamine Mesylate (Deferasirox) ā Ophthalmology, ENT & Other (Ch 10 / Ch 12) • Oral Tridentate Selective Iron(III) Chelator (Transfusional Haemosiderosis Agent) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Desirox (Cipla ā 250 mg, 500 mg Dispersible & 180 mg, 360 mg Film-Coated), Asunra (Novartis ā 100 mg, 400 mg Dispersible)
- [V340.6-099] Eltrombopag Olamine & Romiplostim (Eltrombopag Olamine) ā Ophthalmology, ENT & Other (Ch 03 / Ch 12) • Oral Non-Peptide Thrombopoietin Receptor (TPO-R / c-Mpl) Agonist • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Revolade (Novartis India ā 25 mg, 50 mg), Trombonat (Natco ā 25 mg, 50 mg)
- [V340.6-100] Naltrexone Hydrochloride & Acamprosate Calcium (Naltrexone Hydrochloride) ā Ophthalmology, ENT & Other (Ch 11 / Ch 12) • Competitive Pure Mu-Opioid Receptor Antagonist & Glutamatergic NMDA Modulator (Relapse Prevention) • Schedule H (Drugs Rules, 1945 ā Prescription Only) • Brands: Naltima (Intas ā 50 mg Naltrexone), Nodict (Sun Pharma ā 50 mg Naltrexone)